STAT Plus: Pharmalittle: U.S. plans ‘Operation Warp Speed’ for a Covid-19 vaccine; Gilead vows remdesivir will be accessible
Top of the morning to you. Despite some gloomy skies and a spot of rain, we are starting the day with an optimistic outlook. After all, as the Morning Mayor taught us long ago, every new day should be unwrapped like a precious gift. A notion to take to heart during times like these, yes? So let us move on with the usual rituals — firing up the coffee kettle and foraging for items of interest. On that note, here are a few to get you started on your own mission. Hope all goes well today and you conquer the world, such as it is. …
The Trump administration is organizing a Manhattan Project-style effort to drastically cut the time needed to develop a Covid-19 vaccine, with a goal of making enough doses for most Americans by year’s end, Bloomberg News reports. “Operation Warp Speed” will pull together drug makers, government agencies, and the military to try to cut development time for a vaccine by as much as eight months. As part of the arrangement, taxpayers will shoulder much of the financial risk that vaccine candidates may fail, instead of drug companies.
Continue to STAT Plus to read the full story…
